Dr Monika Metzger, MD | |
262 Danny Thomas Pl # Ms 515, C/o Dana Cannon, Memphis, TN 38105-3678 | |
(901) 595-3006 | |
(901) 595-3842 |
Full Name | Dr Monika Metzger |
---|---|
Gender | Female |
Speciality | Pediatrics - Pediatric Hematology-oncology |
Location | 262 Danny Thomas Pl # Ms 515, Memphis, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013914662 | NPI | - | NPPES |
207235904 | Medicaid | MO | |
009998465 | Medicaid | AL | |
200056690A | Medicaid | OK | |
177222001 | Medicaid | TX | |
200520160A | Medicaid | IN | |
0147771 | Medicaid | MT | |
200379210A | Medicaid | KS | |
7615330 | Medicaid | NC | |
5440555 | Medicaid | TN | |
64099716 | Medicaid | KY | |
09652249 | Medicaid | MS | |
158824001 | Medicaid | AR | |
1777978 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0207X | Pediatrics - Pediatric Hematology-oncology | 39718 (Tennessee) | Primary |
Entity Name | Marys Center For Maternal And Child Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962520288 PECOS PAC ID: 5092798298 Enrollment ID: O20040609000873 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
CANCER RESEARCH UK scientists have shown for the first time how preventing two receptors - 'cell antennae' - communicating with each other can influence the activity of oestrogen, the hormone that fuels the progression of breast cancer in many women. The research is published in Genes and Development.
Pharmaceutical company Pharmaxis today announced the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the granting of a Marketing Authorisation for Bronchitol, clearing the way for the product to be used in Europe "for the treatment of cystic fibrosis in adults as an add-on therapy to best standard of care."
A new study by the International Agency for Research on Cancer (IARC) has provided further evidence that professional painters may face a higher risk of developing bladder cancer than the general population.
Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Monika Metzger, MD 262 Danny Thomas Pl, Ms 515, Memphis, TN 38105-3678 Ph: (901) 595-3006 | Dr Monika Metzger, MD 262 Danny Thomas Pl # Ms 515, C/o Dana Cannon, Memphis, TN 38105-3678 Ph: (901) 595-3006 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
CANCER RESEARCH UK scientists have shown for the first time how preventing two receptors - 'cell antennae' - communicating with each other can influence the activity of oestrogen, the hormone that fuels the progression of breast cancer in many women. The research is published in Genes and Development.
Pharmaceutical company Pharmaxis today announced the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the granting of a Marketing Authorisation for Bronchitol, clearing the way for the product to be used in Europe "for the treatment of cystic fibrosis in adults as an add-on therapy to best standard of care."
A new study by the International Agency for Research on Cancer (IARC) has provided further evidence that professional painters may face a higher risk of developing bladder cancer than the general population.
Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.
› Verified 9 days ago
Dr. Andrew Buchman Nearn, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2861 Broad Ave, Memphis, TN 38112 Phone: 901-701-2520 Fax: 901-325-6469 | |
Dr. Michael William Bishop, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 262 Danny Thomas Pl, Memphis, TN 38105 Phone: 888-226-4343 | |
Mimily Harsono, MD Pediatrics Medicare: Medicare Enrolled Practice Location: University Of Tennessee (division Of Neonatology), 853 Jefferson Avenue, Suite-201, Newborn Center, Memphis, TN 38103 Phone: 901-448-5950 Fax: 901-448-1691 | |
Mr. Alberto S. Pappo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 262 Danny Thomas Pl, Memphis, TN 38105 Phone: 901-595-6765 Fax: 901-521-9005 | |
Dr. Darlene K Cash, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 100 N Humphreys Blvd, Memphis, TN 38120 Phone: 901-322-9080 Fax: 901-322-2994 | |
Benjamin R Waller Iii, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 51 N Dunlap St Fl 2, Memphis, TN 38105 Phone: 901-287-7337 Fax: 901-287-4646 |